RNA, U4atac small nuclear 5, pseudogene (RNU4ATAC5P)

RNU4ATAC5P is a *pseudogene* of the small nuclear RNA gene RNU4ATAC, which encodes U4atac, an essential component of the minor (U12-dependent) spliceosome involved in the splicing of a specialized subset of introns from pre-messenger RNAs[1][5][4]. As a pseudogene, RNU4ATAC5P does not produce a functional snRNA product and has no known biological activity, therapeutic role, or disease association. The functional *RNU4ATAC* gene (not the pseudogene) is linked to developmental disorders such as microcephalic osteodysplastic primordial dwarfism type I (MOPD I), Taybi-Linder syndrome, Roifman syndrome, and Lowry Wood syndrome[1][3][4][5]. The pseudogene RNU4ATAC5P is most likely a non-functional genomic sequence with no current evidence supporting any role in human biology or disease. Explanation of “is_incorrect”: The entity referenced (“RNA, U4atac small nuclear 5, pseudogene”/RNU4ATAC5P) is a pseudogene, not a therapeutic target, and pseudogenes generally do not encode proteins, functional RNAs, or serve as drug targets. The relevant, functional molecule is "RNA, U4atac small nuclear (U12-dependent splicing)" or RNU4ATAC[1][4][5]. The pseudogene is not biologically active and should not be considered a valid target. What’s missing/inaccurate: - Pseudogenes, by definition, are non-functional remnants of genes and are not established drug targets, receptors, enzymes, or transporters. - The functional analog is RNU4ATAC, not RNU4ATAC5P. - There is no evidence supporting a role in disease, no known function, and no therapeutic relevance for RNU4ATAC5P. Summary: RNU4ATAC5P is a non-functional RNA pseudogene and not a biomedical target. If you are interested in the biologically significant minor spliceosome snRNA, search for RNU4ATAC (not RNU4ATAC5P)[1][5][4].

Other names

RNU4ATAC5PRNA, U4atac small nuclear 5, pseudogeneU4atac-5p